|
Symbol |
Object Name |
Qualifiers |
Evidence |
Notes |
Source |
PubMed Reference(s) |
RGD Reference(s) |
Position |
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
ISO |
[Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of ABCC2 mRNA |
CTD |
PMID:32745781 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions |
ISO |
[Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of ABCC3 mRNA |
CTD |
PMID:32745781 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
multiple interactions |
ISO |
[Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of ACOX1 mRNA |
CTD |
PMID:32736067 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
EXP |
Ziram results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:30422632 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Amh |
anti-Mullerian hormone |
decreases expression increases expression |
EXP |
Ziram results in decreased expression of AMH mRNA; Ziram results in decreased expression of AMH protein Ziram results in increased expression of AMH mRNA |
CTD |
PMID:29627606 PMID:30422632 |
|
NCBI chr 7:8,906,776...8,909,192
Ensembl chr 7:8,906,836...8,909,282
|
|
G |
Apln |
apelin |
increases expression |
ISO |
Ziram results in increased expression of APLN mRNA |
CTD |
PMID:32870474 |
|
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
EXP |
Ziram results in increased expression of BAX protein |
CTD |
PMID:28973382 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
EXP |
Ziram results in decreased expression of BCL2 protein |
CTD |
PMID:28973382 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Ziram results in decreased expression of and results in increased degradation of CASP1 protein]; Dithiothreitol inhibits the reaction [Ziram results in decreased expression of and results in increased degradation of CASP1 protein]; Edetic Acid inhibits the reaction [Ziram results in decreased expression of and results in increased degradation of CASP1 protein]; Mercaptoethanol inhibits the reaction [Ziram results in decreased expression of and results in increased degradation of CASP1 protein]; Ziram results in decreased expression of and results in increased degradation of CASP1 protein |
CTD |
PMID:25929180 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
Ziram results in increased activity of CASP3 protein |
CTD |
PMID:20842346 PMID:22159898 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
Ziram results in increased activity of CASP8 protein |
CTD |
PMID:22159898 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Ziram results in increased activity of CASP9 protein |
CTD |
PMID:22159898 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases expression |
ISO |
Ziram results in increased expression of CAT mRNA |
CTD |
PMID:32712770 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases secretion |
ISO |
Ziram inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] Ziram results in decreased secretion of CCL2 protein |
CTD |
PMID:32712770 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnd3 |
cyclin D3 |
decreases expression |
EXP |
Ziram results in decreased expression of CCND3 mRNA |
CTD |
PMID:28973382 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
increases expression decreases expression |
ISO |
Ziram results in increased expression of CCR2 mRNA Ziram results in decreased expression of CCR2 protein |
CTD |
PMID:32712770 |
|
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Cd163 |
CD163 molecule |
decreases expression |
ISO |
Ziram results in decreased expression of CD163 mRNA; Ziram results in decreased expression of CD163 protein |
CTD |
PMID:32712770 |
|
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd209d |
CD209d molecule |
increases expression |
ISO |
Ziram results in increased expression of CD209 mRNA; Ziram results in increased expression of CD209 protein |
CTD |
PMID:32712770 |
|
NCBI chr12:6,689,002...6,695,452
Ensembl chr12:1,891,113...1,901,171
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions decreases expression |
ISO |
[Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CD36 mRNA Ziram results in decreased expression of CD36 mRNA; Ziram results in decreased expression of CD36 protein |
CTD |
PMID:32712770 PMID:32736067 |
|
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Clec7a |
C-type lectin domain containing 7A |
decreases expression |
ISO |
Ziram results in decreased expression of CLEC7A protein |
CTD |
PMID:32712770 |
|
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
|
|
G |
Cnn2 |
calponin 2 |
increases expression |
ISO |
Ziram results in increased expression of CNN2 mRNA |
CTD |
PMID:32870474 |
|
NCBI chr 7:9,712,505...9,719,678
Ensembl chr 7:9,712,516...9,719,656
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
multiple interactions |
ISO |
[Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CPT1A mRNA |
CTD |
PMID:32736067 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization |
ISO |
Ziram affects the localization of CYCS protein |
CTD |
PMID:20842346 PMID:22159898 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases activity decreases expression affects expression |
EXP |
Ziram results in decreased activity of CYP11A1 protein Ziram results in decreased expression of CYP11A1 mRNA; Ziram results in decreased expression of CYP11A1 protein Ziram affects the expression of CYP11A1 mRNA; Ziram affects the expression of CYP11A1 protein |
CTD |
PMID:28973382 PMID:29627606 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression decreases activity affects expression |
EXP |
Ziram results in decreased expression of CYP17A1 mRNA; Ziram results in decreased expression of CYP17A1 protein Ziram results in decreased activity of CYP17A1 protein Ziram affects the expression of CYP17A1 mRNA; Ziram affects the expression of CYP17A1 protein |
CTD |
PMID:28973382 PMID:29627606 PMID:30422632 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
[Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B10 mRNA; [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CYP2B10 mRNA |
CTD |
PMID:32736067 PMID:32745781 |
|
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c24 |
cytochrome P450, family 2, subfamily c, polypeptide 24 |
multiple interactions |
ISO |
[Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CYP2C55 mRNA |
CTD |
PMID:32736067 |
|
NCBI chr 1:236,873,967...236,936,238
Ensembl chr 1:236,873,967...236,936,238
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
multiple interactions |
ISO |
[Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2C29 mRNA |
CTD |
PMID:32745781 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Ziram results in increased expression of DDIT3 mRNA |
CTD |
PMID:32870474 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dhh |
desert hedgehog signaling molecule |
decreases expression |
EXP |
Ziram results in decreased expression of DHH mRNA; Ziram results in decreased expression of DHH protein |
CTD |
PMID:29627606 |
|
NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
multiple interactions |
ISO |
[Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of DIO1 mRNA |
CTD |
PMID:32745781 |
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
multiple interactions |
ISO |
[Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of ECI1 mRNA |
CTD |
PMID:32736067 |
|
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
|
|
G |
Elfn2 |
extracellular leucine-rich repeat and fibronectin type III domain containing 2 |
increases expression |
ISO |
Ziram results in increased expression of ELFN2 mRNA |
CTD |
PMID:32870474 |
|
NCBI chr 7:110,220,293...110,272,770
Ensembl chr 7:110,225,919...110,272,433
|
|
G |
Fcgr3a |
Fc gamma receptor 3A |
decreases expression |
ISO |
Ziram results in decreased expression of FCGR3A protein |
CTD |
PMID:18670896 |
|
NCBI chr13:85,782,636...85,792,656
Ensembl chr13:83,249,872...83,259,921
|
|
G |
Fibin |
fin bud initiation factor homolog |
increases expression |
ISO |
Ziram results in increased expression of FIBIN mRNA |
CTD |
PMID:32870474 |
|
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
decreases expression |
EXP |
Ziram results in decreased expression of FSHB mRNA; Ziram results in decreased expression of FSHB protein |
CTD |
PMID:28973382 PMID:30422632 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fshr |
follicle stimulating hormone receptor |
decreases expression |
EXP |
Ziram results in decreased expression of FSHR mRNA; Ziram results in decreased expression of FSHR protein |
CTD |
PMID:29627606 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
ISO |
[Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of GFAP protein |
CTD |
PMID:32736067 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gzma |
granzyme A |
decreases expression |
ISO |
Ziram results in decreased expression of GZMA protein |
CTD |
PMID:22038140 |
|
NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:44,740,569...44,752,493
|
|
G |
Gzmb |
granzyme B |
decreases expression |
ISO |
Ziram results in decreased expression of GZMB protein |
CTD |
PMID:21859362 PMID:22038140 |
|
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
|
|
G |
Gzmk |
granzyme K |
decreases expression |
ISO |
Ziram results in decreased expression of GZMK protein |
CTD |
PMID:22038140 |
|
NCBI chr 2:44,840,811...44,848,829
Ensembl chr 2:44,840,811...44,848,894
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
multiple interactions |
ISO |
[Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of HMGCS2 mRNA |
CTD |
PMID:32745781 |
|
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
Trientine inhibits the reaction [Ziram results in increased expression of HMOX1 protein] Ziram results in increased expression of HMOX1 mRNA; Ziram results in increased expression of HMOX1 protein |
CTD |
PMID:25714994 PMID:32712770 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
multiple interactions decreases activity decreases expression |
EXP |
Ziram inhibits the reaction [[HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] which results in increased chemical synthesis of Corticosterone]; Ziram inhibits the reaction [HSD11B1 protein results in increased oxidation of NADP]; Ziram inhibits the reaction [HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] Ziram results in decreased activity of HSD11B1 protein Ziram results in decreased expression of HSD11B1 mRNA; Ziram results in decreased expression of HSD11B1 protein |
CTD |
PMID:26859423 PMID:28973382 |
|
NCBI chr13:107,277,526...107,327,462
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions decreases activity |
ISO EXP |
Dithiothreitol inhibits the reaction [Ziram results in decreased activity of HSD11B2 protein]; Ziram inhibits the reaction [[HSD11B2 protein results in increased oxidation of Hydrocortisone] which results in increased chemical synthesis of Cortisone]; Ziram inhibits the reaction [HSD11B2 protein results in increased oxidation of Hydrocortisone]; Ziram inhibits the reaction [HSD11B2 protein results in increased reduction of NAD] Dithiothreitol inhibits the reaction [Ziram results in decreased activity of HSD11B2 protein]; Ziram inhibits the reaction [[HSD11B2 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone]; Ziram inhibits the reaction [HSD11B2 protein results in increased oxidation of Corticosterone]; Ziram inhibits the reaction [HSD11B2 protein results in increased reduction of NAD] |
CTD |
PMID:26859423 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
decreases activity decreases expression |
EXP |
Ziram results in decreased activity of HSD17B3 protein Ziram results in decreased expression of HSD17B3 mRNA; Ziram results in decreased expression of HSD17B3 protein |
CTD |
PMID:28973382 PMID:29627606 PMID:30422632 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases activity decreases expression |
EXP |
Ziram results in decreased activity of HSD3B1 protein Ziram results in decreased expression of HSD3B1 mRNA; Ziram results in decreased expression of HSD3B1 protein |
CTD |
PMID:28973382 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Ifnb1 |
interferon beta 1 |
multiple interactions |
ISO |
Ziram inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA] |
CTD |
PMID:18177342 |
|
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Ifng |
interferon gamma |
increases expression |
ISO |
Ziram results in increased expression of IFNG protein |
CTD |
PMID:12062936 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Ziram inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] Ziram inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein] |
CTD |
PMID:25929180 PMID:32712770 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
increases expression |
ISO |
Ziram results in increased expression of IL4 protein |
CTD |
PMID:12062936 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Ziram inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] |
CTD |
PMID:32712770 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
ISO |
[Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of INS1 protein |
CTD |
PMID:32745781 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Insl3 |
insulin-like 3 |
decreases expression |
EXP |
Ziram results in decreased expression of INSL3 mRNA; Ziram results in decreased expression of INSL3 protein |
CTD |
PMID:29627606 |
|
NCBI chr16:18,398,682...18,400,566
Ensembl chr16:18,384,829...18,400,560
|
|
G |
Itgam |
integrin subunit alpha M |
increases expression |
ISO |
Ziram results in increased expression of ITGAM mRNA; Ziram results in increased expression of ITGAM protein |
CTD |
PMID:32712770 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Lep |
leptin |
multiple interactions |
EXP |
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of LEP protein |
CTD |
PMID:29321614 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lepr |
leptin receptor |
multiple interactions |
EXP |
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in decreased expression of LEPR mRNA |
CTD |
PMID:29321614 |
|
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
decreases expression affects expression |
EXP |
Ziram results in decreased expression of LHCGR mRNA; Ziram results in decreased expression of LHCGR protein Ziram affects the expression of LHCGR mRNA; Ziram affects the expression of LHCGR protein |
CTD |
PMID:28973382 PMID:29627606 PMID:30422632 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases activity |
ISO |
Ziram results in increased activity of MAPK1 protein |
CTD |
PMID:21859362 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases activity |
ISO |
Ziram results in increased activity of MAPK3 protein |
CTD |
PMID:21859362 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
decreases expression |
ISO |
Ziram results in decreased expression of MRC1 protein |
CTD |
PMID:32712770 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
|
|
G |
Mt1-ps3 |
metallothionein 1, pseudogene 3 |
increases expression |
ISO |
Ziram results in increased expression of MT1E mRNA |
CTD |
PMID:32870474 |
|
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
|
|
G |
Mt2 |
metallothionein 2 |
increases expression |
ISO |
Ziram results in increased expression of MT2A mRNA |
CTD |
PMID:32870474 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mt4 |
metallothionein 4 |
decreases expression |
ISO |
Ziram results in decreased expression of MT4 mRNA |
CTD |
PMID:32870474 |
|
NCBI chr19:10,863,813...10,865,909
Ensembl chr19:10,863,813...10,865,909
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects expression |
ISO |
Ziram affects the expression of NFE2L2 mRNA |
CTD |
PMID:32712770 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
Ziram inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] |
CTD |
PMID:17015962 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
decreases expression |
ISO |
Ziram results in decreased expression of NLRP3 protein |
CTD |
PMID:25929180 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nmb |
neuromedin B |
multiple interactions |
EXP |
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in decreased expression of NMB mRNA |
CTD |
PMID:29321614 |
|
NCBI chr 1:134,869,446...134,875,507
Ensembl chr 1:134,869,446...134,872,190
|
|
G |
Nmbr |
neuromedin B receptor |
multiple interactions |
EXP |
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of NMBR mRNA |
CTD |
PMID:29321614 |
|
NCBI chr 1:9,115,033...9,146,081
Ensembl chr 1:9,134,889...9,145,462
|
|
G |
Npy1r |
neuropeptide Y receptor Y1 |
multiple interactions |
EXP |
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of NPY1R mRNA |
CTD |
PMID:29321614 |
|
NCBI chr16:23,037,788...23,047,330
Ensembl chr16:23,037,789...23,046,759
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
ISO |
NR1I3 protein affects the susceptibility to [2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with Thiophanate co-treated with thiacloprid co-treated with Ziram] |
CTD |
PMID:29950287 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
decreases expression affects expression |
EXP |
Ziram results in decreased expression of NR5A1 mRNA; Ziram results in decreased expression of NR5A1 protein Ziram affects the expression of NR5A1 mRNA; Ziram affects the expression of NR5A1 protein |
CTD |
PMID:28973382 PMID:29627606 |
|
NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328
|
|
G |
Park7 |
Parkinsonism associated deglycase |
decreases activity |
ISO |
Ziram results in decreased activity of PARK7 protein |
CTD |
PMID:36842454 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
multiple interactions |
ISO |
[Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of PDGFRB protein |
CTD |
PMID:32736067 |
|
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
affects expression |
ISO |
Ziram affects the expression of PDK4 mRNA |
CTD |
PMID:32870474 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
affects expression |
ISO |
Ziram affects the expression of PPARG mRNA |
CTD |
PMID:32712770 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
decreases expression |
EXP |
Ziram results in decreased expression of PPARGC1A protein |
CTD |
PMID:30422632 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Prf1 |
perforin 1 |
decreases expression |
ISO |
Ziram results in decreased expression of PRF1 protein |
CTD |
PMID:21859362 PMID:22038140 |
|
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
|
|
G |
Prss56 |
serine protease 56 |
increases expression |
ISO |
Ziram results in increased expression of PRSS56 mRNA |
CTD |
PMID:32870474 |
|
NCBI chr 9:87,842,806...87,859,978
Ensembl chr 9:87,854,805...87,859,978
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
decreases expression affects expression |
EXP |
Ziram results in decreased expression of SCARB1 mRNA; Ziram results in decreased expression of SCARB1 protein Ziram affects the expression of SCARB1 mRNA; Ziram affects the expression of SCARB1 protein |
CTD |
PMID:28973382 PMID:29627606 PMID:30422632 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions |
ISO |
[Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of SERPINE1 mRNA |
CTD |
PMID:32745781 |
|
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sirt1 |
sirtuin 1 |
decreases expression |
EXP |
Ziram results in decreased expression of SIRT1 protein |
CTD |
PMID:30422632 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc16a2 |
solute carrier family 16 member 2 |
multiple interactions |
ISO |
[Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of SLC16A2 mRNA |
CTD |
PMID:32745781 |
|
NCBI chr X:68,725,365...68,848,572
Ensembl chr X:68,723,261...68,848,771
|
|
G |
Slc30a1 |
solute carrier family 30 member 1 |
increases expression |
ISO |
Ziram results in increased expression of SLC30A1 mRNA |
CTD |
PMID:32870474 |
|
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
|
|
G |
Slc30a2 |
solute carrier family 30 member 2 |
increases expression |
ISO |
Ziram results in increased expression of SLC30A2 mRNA |
CTD |
PMID:32870474 |
|
NCBI chr 5:146,559,733...146,571,957
Ensembl chr 5:146,559,733...146,571,956
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
Ziram results in increased expression of SLC7A11 mRNA |
CTD |
PMID:32870474 |
|
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc8a3 |
solute carrier family 8 member A3 |
increases response to substance decreases response to substance |
EXP ISO |
SLC8A3 results in increased susceptibility to Ziram SLC8A3 gene mutant form results in decreased susceptibility to Ziram |
CTD |
PMID:25284465 |
|
NCBI chr 6:100,874,359...101,007,989
Ensembl chr 6:100,874,369...101,007,508
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions |
ISO |
Ziram inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:31652400 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Snca |
synuclein alpha |
increases expression |
EXP |
Ziram results in increased expression of SNCA protein |
CTD |
PMID:18818210 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression |
ISO |
Ziram results in increased expression of SOD2 mRNA |
CTD |
PMID:32712770 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
decreases expression |
EXP |
Ziram results in decreased expression of SOX9 mRNA; Ziram results in decreased expression of SOX9 protein |
CTD |
PMID:29627606 |
|
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
decreases expression decreases activity |
EXP |
Ziram results in decreased expression of SRD5A1 mRNA Ziram results in decreased activity of SRD5A1 protein |
CTD |
PMID:28707553 PMID:30422632 |
|
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression affects expression |
EXP |
Ziram results in decreased expression of STAR mRNA; Ziram results in decreased expression of STAR protein Ziram affects the expression of STAR mRNA; Ziram affects the expression of STAR protein |
CTD |
PMID:28973382 PMID:29627606 PMID:30422632 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Sult1b1 |
sulfotransferase family 1B member 1 |
multiple interactions |
ISO |
[Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of SULT1B1 mRNA |
CTD |
PMID:32745781 |
|
NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,492,708...20,505,483
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases activity multiple interactions |
ISO |
Ziram results in decreased activity of TGFB1 protein Ziram inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:31652400 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Thrsp |
thyroid hormone responsive |
multiple interactions |
ISO |
[2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of THRSP mRNA; [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in decreased expression of THRSP mRNA; Dietary Fats inhibits the reaction [[2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of THRSP mRNA] |
CTD |
PMID:32745781 |
|
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Ziram inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] |
CTD |
PMID:16112155 PMID:32712770 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tpo |
thyroid peroxidase |
decreases activity |
ISO |
Ziram results in decreased activity of TPO protein |
CTD |
PMID:9248629 |
|
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
|
|
G |
Tspo |
translocator protein |
decreases expression |
EXP |
Ziram results in decreased expression of TSPO mRNA |
CTD |
PMID:28973382 |
|
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
|
|
G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
decreases activity multiple interactions |
ISO |
Ziram results in decreased activity of UBA1 protein Trientine inhibits the reaction [Ziram results in decreased activity of and results in decreased ubiquitination of UBA1 protein]; Ziram results in decreased activity of and results in decreased ubiquitination of UBA1 protein |
CTD |
PMID:18818210 PMID:25714994 |
|
NCBI chr X:1,508,700...1,530,677
Ensembl chr X:1,508,666...1,530,636
|
|